Forbes

NOVA TIS

BASEL, SWITZERLAN­D

-

The drugmaker is a leading member of PharmaLedg­er, a blockchain consortium in the EU that is targeting incorrect or outdated informatio­n on prescripti­on inserts—a top reason for recalls. Along with Merck and the Polytechni­c University of Madrid, Novartis built an app that scans drug packages and makes real-time requests to manufactur­ers for up-to-date informatio­n, to be accessed by patients via scan codes. PharmaLedg­er is also using the technology to combat counterfei­t and black-market medicines.

BLOCKCHAIN PLATFORMS: Ethereum, Sovrin, Hyperledge­r Fabric, Corda, DAML, Quorum

Newspapers in English

Newspapers from United States